Effect of the multimodal acting antidepressant vortioxetine on rat hippocampal plasticity and recognition memory

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 58, Issue , 2015, Pages 38-46

  Bétry, Cécile ^a   Etiévant, Adeline ^a   Pehrson, Alan ^b   Sánchez, Connie ^b   Haddjeri, Nasser ^a  

^a UNIVERSITÉ LYON 1   (France)

^b LUNDBECK RESEARCH USA   (United States)

Author keywords

Antidepressant; LTP; Memory; Neurogenesis; Novel object recognition; Vortioxetine

Indexed keywords

4 AMINO 1 (6 CHLORO 2 PYRIDYL)PIPERIDINE; FLUOXETINE; SEROTONIN 3 RECEPTOR; SEROTONIN TRANSPORTER; VORTIOXETINE; ANTIDEPRESSANT AGENT; PIPERAZINE DERIVATIVE; RNA BINDING PROTEIN; SEROTONIN 3 ANTAGONIST; SERT PROTEIN, RAT; SULFIDE;

ACUTE STRESS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DENTATE GYRUS; EPISODIC MEMORY; HIPPOCAMPAL CA1 REGION; HIPPOCAMPUS; LONG TERM POTENTIATION; MALE; MEMORY; NERVE CELL PLASTICITY; NONHUMAN; NOVEL OBJECT RECOGNITION TEST; RAT; RECEPTOR OCCUPANCY; SHORT TERM MEMORY; SINGLE DRUG DOSE; ANIMAL; COHORT ANALYSIS; COMPARATIVE STUDY; DRUG EFFECTS; DRUG THERAPY; EXCITATORY POSTSYNAPTIC POTENTIAL; EXPLORATORY BEHAVIOR; MENTAL STRESS; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; RECOGNITION; SPRAGUE DAWLEY RAT;

ANIMALS; ANTIDEPRESSIVE AGENTS; CELL PROLIFERATION; COHORT STUDIES; EXCITATORY POSTSYNAPTIC POTENTIALS; EXPLORATORY BEHAVIOR; FLUOXETINE; HIPPOCAMPUS; LONG-TERM POTENTIATION; MALE; MEMORY, EPISODIC; MEMORY, SHORT-TERM; PIPERAZINES; RATS, SPRAGUE-DAWLEY; RECEPTORS, SEROTONIN, 5-HT3; RECOGNITION (PSYCHOLOGY); RNA-BINDING PROTEINS; SEROTONIN 5-HT3 RECEPTOR ANTAGONISTS; STRESS, PSYCHOLOGICAL; SULFIDES;

EID: 84920159775     PISSN: 02785846     EISSN: 18784216     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2014.12.002     Document Type: Article

References (81)

1. Abrial E., Bétourné E., Etiévant A., Lucas G., Scarna H., Lambás-Señas L., et al. Protein kinase C inhibition rescues manic-like behaviors and hippocampal cell proliferation deficits in the sleep deprivation model of mania. Int J Neuropsychopharmacol 2014, (in press). 10.1093/ijnp/pyu031.
2. Adell A. Lu-AA21004, a multimodal serotonergic agent, for the potential treatment of depression and anxiety. IDrugs 2010, 13:900-910.
3. Akhondzadeh S., Mohammadi N., Noroozian M., Karamghadiri N., Ghoreishi A., Jamshidi A.H., et al. Added ondansetron for stable schizophrenia: a double blind, placebo controlled trial. Schizophr Res 2009, 107:206-212.
4. Alvarez E., Perez V., Dragheim M., Loft H., Artigas F. A double-blind, randomized, placebo-controlled, active reference study of Lu AA21004 in patients with major depressive disorder. Int J Neuropsychopharmacol 2012, 15:589-600.
5. Areberg J., Luntang-Jensen M., Sogaard B., Nilausen D.O. Occupancy of the serotonin transporter after administration of Lu AA21004 and its relation to plasma concentration in healthy subjects. Basic Clin Pharmacol Toxicol 2012, 110:401-404.
6. Arnsten A.F., Lin C.H., Van Dyck C.H., Stanhope K.J. The effects of 5-HT3 receptor antagonists on cognitive performance in aged monkeys. Neurobiol Aging 1997, 18:21-28.
7. Azmitia E.C., Segal M. An autoradiographic analysis of the differential ascending projections of the dorsal and median raphe nuclei in the rat. J Comp Neurol 1978, 179:641-667.
8. Banasr M., Soumier A., Hery M., Mocaer E., Daszuta A. Agomelatine, a new antidepressant, induces regional changes in hippocampal neurogenesis. Biol Psychiatry 2006, 59:1087-1096.
9. Bang-Andersen B., Ruhland T., Jorgensen M., Smith G., Frederiksen K., Jensen K.G., et al. Discovery of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): a novel multimodal compound for the treatment of major depressive disorder. J Med Chem 2011, 54:3206-3221.
10. Barnes J.M., Costall B., Coughlan J., Domeney A.M., Gerrard P.A., Kelly M.E., et al. The effects of ondansetron, a 5-HT3 receptor antagonist, on cognition in rodents and primates. Pharmacol Biochem Behav 1990, 35:955-962.
11. Bartolini L., Casamenti F., Pepeu G. Aniracetam restores object recognition impaired by age, scopolamine, and nucleus basalis lesions. Pharmacol Biochem Behav 1996, 53:277-283.
12. Basso M.R., Bornstein R.A. Relative memory deficits in recurrent versus first-episode major depression on a word-list learning task. Neuropsychology 1999, 13:557-563.
13. Baune B.T., Miller R., McAfoose J., Johnson M., Quirk F., Mitchell D. The role of cognitive impairment in general functioning in major depression. Psychiatry Res 2010, 176:183-189.
14. Belmaker R.H., Agam G. Major depressive disorder. N Engl J Med 2008, 358:55-68.
15. Bertaina-Anglade V., Enjuanes E., Morillon D., Drieu la Rochelle C. The object recognition task in rats and mice: a simple and rapid model in safety pharmacology to detect amnesic properties of a new chemical entity. J Pharmacol Toxicol Methods 2006, 54:99-105.
16. Bertaina-Anglade V., Drieu-La-Rochelle C., Mocaer E., Seguin L. Memory facilitating effects of agomelatine in the novel object recognition memory paradigm in the rat. Pharmacol Biochem Behav 2011, 98:511-517.
17. Betry C., Pehrson A.L., Etievant A., Ebert B., Sánchez C., Haddjeri N. The rapid recovery of 5-HT cell firing induced by the antidepressant vortioxetine involves 5-HT(3) receptor antagonism. Int J Neuropsychopharmacol 2013, 16:1115-1127.
18. Buhot M.C. Serotonin receptors in cognitive behaviors. Curr Opin Neurobiol 1997, 7:243-254.
19. Buhot M.C., Martin S., Segu L. Role of serotonin in memory impairment. Ann Med 2000, 32:210-221.
20. Caudal D., Jay T.M., Godsil B.P. Behavioral stress induces regionally-distinct shifts of brain mineralocorticoid and glucocorticoid receptor levels. Front Behav Neurosci 2014, 8:19. 10.3389/fnbeh.2014.00019.
21. Cazakoff B.N., Howland J.G. Acute stress disrupts paired pulse facilitation and long-term potentiation in rat dorsal hippocampus through activation of glucocorticoid receptors. Hippocampus 2010, 20:1327-1331.
22. Cohen S.J., Stackman R.W. Assessing rodent hippocampal involvement in the novel object recognition task. Behav Brain Res 2014, (in press). 10.1016/j.bbr.2014.08.002.
23. Conradi H.J., Ormel J., de Jonge P. Presence of individual (residual) symptoms during depressive episodes and periods of remission: a 3-year prospective study. Psychol Med 2011, 41:1165-1174.
24. Cooke J.D., Grover L.M., Spangler P.R. Venlafaxine treatment stimulates expression of brain-derived neurotrophic factor protein in frontal cortex and inhibits long-term potentiation in hippocampus. Neuroscience 2009, 162:1411-1419.
25. Corradetti R., Ballerini L., Pugliese A.M., Pepeu G. Serotonin blocks the long-term potentiation induced by primed burst stimulation in the CA1 region of rat hippocampal slices. Neuroscience 1992, 46:511-518.
26. Czachura J.F., Rasmussen K. Effects of acute and chronic administration of fluoxetine on the activity of serotonergic neurons in the dorsal raphe nucleus of the rat. Naunyn Schmiedebergs Arch Pharmacol 2000, 362:266-275.
27. Dale E., Zhang H., Leiser S.C., Xiao Y., Lu D., Yang C.R., et al. Vortioxetine disinhibits pyramidal cell function and enhances synaptic plasticity in the rat hippocampus. J Psychopharmacol 2014, 28:891-902.
28. Dere E., Huston J.P., De Souza Silva M.A. The pharmacology, neuroanatomy and neurogenetics of one-trial object recognition in rodents. Neurosci Biobehav Rev 2007, 31:673-704.
29. du Jardin K.G., Jensen J.B., Sánchez C., Pehrson A.L. Vortioxetine dose-dependently reverses 5-HT depletion-induced deficits in spatial working and object recognition memory: A potential role for 5-HT receptor agonism and 5-HT receptor antagonism. Eur Neuropsychopharmacol 2014, 24:160-171.
30. Duman R.S. Depression: a case of neuronal life and death?. Biol Psychiatry 2004, 56:140-145.
31. Egeland J., Rund B.R., Sundet K., Landro N.I., Asbjornsen A., Lund A., et al. Attention profile in schizophrenia compared with depression: differential effects of processing speed, selective attention and vigilance. Acta Psychiatr Scand 2003, 108:276-284.
32. Felice D., O'Leary O.F., Pizzo R.C., Cryan J.F. Blockade of the GABA(B) receptor increases neurogenesis in the ventral but not dorsal adult hippocampus: relevance to antidepressant action. Neuropharmacology 2012, 63:1380-1388.
33. Fontana D.J., Daniels S.E., Henderson C., Eglen R.M., Wong E.H. Ondansetron improves cognitive performance in the Morris water maze spatial navigation task. Psychopharmacology (Berl) 1995, 120:409-417.
34. Gomez-Galan M., De Bundel D., Van Eeckhaut A., Smolders I., Lindskog M. Dysfunctional astrocytic regulation of glutamate transmission in a rat model of depression. Mol Psychiatry 2013, 18:582-594.
35. Gorwood P., Corruble E., Falissard B., Goodwin G.M. Toxic effects of depression on brain function: impairment of delayed recall and the cumulative length of depressive disorder in a large sample of depressed outpatients. Am J Psychiatry 2008, 165:731-739.
36. Guilloux J.P., Mendez-David I., Pehrson A., Guiard B.P., Reperant C., Orvoen S., et al. Antidepressant and anxiolytic potential of the multimodal antidepressant vortioxetine (Lu AA21004) assessed by behavioural and neurogenesis outcomes in mice. Neuropharmacology 2013, 73:147-159.
37. Hammar A., Ardal G. Cognitive functioning in major depression-a summary. Front Hum Neurosci 2009, 3:26.
38. Henningsen K., Andreasen J.T., Bouzinova E.V., Jayatissa M.N., Jensen M.S., Redrobe J.P., et al. Cognitive deficits in the rat chronic mild stress model for depression: relation to anhedonic-like responses. Behav Brain Res 2009, 198:136-141.
39. Hodges H., Sowinski P., Turner J.J., Fletcher A. Comparison of the effects of the 5-HT3 receptor antagonists WAY-100579 and ondansetron on spatial learning in the water maze in rats with excitotoxic lesions of the forebrain cholinergic projection system. Psychopharmacology (Berl) 1996, 125:146-161.
40. Howland J.G., Cazakoff B.N. Effects of acute stress and GluN2B-containing NMDA receptor antagonism on object and object-place recognition memory. Neurobiol Learn Mem 2010, 93:261-267.
41. Jensen J.B., du Jardin K.G., Song D., Budac D., Smagin G., Sánchez C., et al. Vortioxetine, but not escitalopram or duloxetine, reverses memory impairment induced by central 5-HT depletion in rats: evidence for direct 5-HT receptor modulation. Eur Neuropsychopharmacol 2013, 24:148-159.
42. Kalueff A.V., Murphy D.L. The importance of cognitive phenotypes in experimental modeling of animal anxiety and depression. Neural Plast 2007, 2007:52087.
43. Katona C., Hansen T., Olsen C.K. A randomized, double-blind, placebo-controlled, duloxetine-referenced, fixed-dose study comparing the efficacy and safety of Lu AA21004 in elderly patients with major depressive disorder. Int Clin Psychopharmacol 2012, 27:215-223.
44. Kim J.J., Foy M.R., Thompson R.F. Behavioral stress modifies hippocampal plasticity through N-methyl-d-aspartate receptor activation. Proc Natl Acad Sci U S A 1996, 93:4750-4753.
45. King M.V., Marsden C.A., Fone K.C. A role for the 5-HT(1A), 5-HT4 and 5-HT6 receptors in learning and memory. Trends Pharmacol Sci 2008, 29:482-492.
46. Kojima T., Matsumoto M., Togashi H., Tachibana K., Kemmotsu O., Yoshioka M. Fluvoxamine suppresses the long-term potentiation in the hippocampal CA1 field of anesthetized rats: an effect mediated via 5-HT1A receptors. Brain Res 2003, 959:165-168.
47. Leiser S.C., Pehrson A.L., Robichaud P.J., Sanchez C. Multimodal antidepressant vortioxetine increases frontal cortical oscillations unlike escitalopram and duloxetine-a quantitative EEG study in rats. Br J Pharmacol 2014, 171:4255-4272.
48. Leung S.W. Potentials evoked by alvear tract in hippocampal CA1 region of rats. II. Spatial field analysis. J Neurophysiol 1979, 42:1571-1589.
49. Li C., Huang P., Lu Q., Zhou M., Guo L., Xu X. KCNQ/Kv7 channel activator flupirtine protects against acute stress-induced impairments of spatial memory retrieval and hippocampal LTP in rats. Neuroscience 2014, 280C:19-30.
50. Malberg J.E., Eisch A.J., Nestler E.J., Duman R.S. Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J Neurosci 2000, 20:9104-9110.
51. Marazziti D., Consoli G., Picchetti M., Carlini M., Faravelli L. Cognitive impairment in major depression. Eur J Pharmacol 2010, 626:83-86.
52. Matsumoto M., Tachibana K., Togashi H., Tahara K., Kojima T., Yamaguchi T., et al. Chronic treatment with milnacipran reverses the impairment of synaptic plasticity induced by conditioned fear stress. Psychopharmacology (Berl) 2005, 179:606-612.
53. Meneses A. A pharmacological analysis of an associative learning task: 5-HT(1) to 5-HT(7) receptor subtypes function on a pavlovian/instrumental autoshaped memory. Learn Mem 2003, 10:363-372.
54. Meneses A., Hong E. A pharmacological analysis of serotonergic receptors: effects of their activation of blockade in learning. Prog Neuropsychopharmacol Biol Psychiatry 1997, 21:273-296.
55. Merriam E.P., Thase M.E., Haas G.L., Keshavan M.S., Sweeney J.A. Prefrontal cortical dysfunction in depression determined by Wisconsin Card Sorting Test performance. Am J Psychiatry 1999, 156:780-782.
56. Miyata S., Shimoi T., Hirano S., Yamada N., Hata Y., Yoshikawa N., et al. Effects of serotonergic anxiolytics on the freezing behavior in the elevated open-platform test in mice. J Pharmacol Sci 2007, 105:272-278.
57. Mnie-Filali O., El Mansari M., Espana A., Sánchez C., Haddjeri N. Allosteric modulation of the effects of the 5-HT reuptake inhibitor escitalopram on the rat hippocampal synaptic plasticity. Neurosci Lett 2006, 395:23-27.
58. Mnie-Filali O., Faure C., Mansari M.E., Lambas-Senas L., Berod A., Zimmer L., et al. R-citalopram prevents the neuronal adaptive changes induced by escitalopram. Neuroreport 2007, 18:1553-1556.
59. Mnie-Filali O., Faure C., Lambas-Senas L., El Mansari M., Belblidia H., Gondard E., et al. Pharmacological blockade of 5-HT(7) receptors as a putative fast acting antidepressant strategy. Neuropsychopharmacology 2011, 36:1275-1288.
60. Mørk A., Pehrson A., Brennum L.T., Nielsen S.M., Zhong H., Lassen A.B., et al. Pharmacological effects of Lu AA21004: a novel multimodal compound for the treatment of major depressive disorder. J Pharmacol Exp Ther 2012, 340:666-675.
61. Mørk A., Montezinho L.P., Miller S., Trippodi-Murphy C., Plath N., Li Y., et al. Vortioxetine (Lu AA21004), a novel multimodal antidepressant, enhances memory in rats. Pharmacol Biochem Behav 2013, 105:41-50.
62. Morris R.G. Long-term potentiation and memory. Philos Trans R Soc Lond B Biol Sci 2003, 358:643-647.
63. Passani M.B., Pugliese A.M., Azzurrini M., Corradetti R. Effects of DAU 6215, a novel 5-hydroxytryptamine3 (5-HT3) antagonist on electrophysiological properties of the rat hippocampus. Br J Pharmacol 1994, 112:695-703.
64. Pehrson A.L., Cremers T., Betry C., van der Hart M.G., Jorgensen L., Madsen M., et al. Lu AA21004, a novel multimodal antidepressant, produces regionally selective increases of multiple neurotransmitters-a rat microdialysis and electrophysiology study. Eur Neuropsychopharmacol 2013, 23:133-145.
65. Pitsikas N., Borsini F. Itasetron (DAU 6215) prevents age-related memory deficits in the rat in a multiple choice avoidance task. Eur J Pharmacol 1996, 311:115-119.
66. Pittenger C., Duman R.S. Stress, depression, and neuroplasticity: a convergence of mechanisms. Neuropsychopharmacology 2008, 33:88-109.
67. Qi H., Mailliet F., Spedding M., Rocher C., Zhang X., Delagrange P., et al. Antidepressants reverse the attenuation of the neurotrophic MEK/MAPK cascade in frontal cortex by elevated platform stress; reversal of effects on LTP is associated with GluA1 phosphorylation. Neuropharmacology 2009, 56:37-46.
68. Rocher C., Spedding M., Munoz C., Jay T.M. Acute stress-induced changes in hippocampal/prefrontal circuits in rats: effects of antidepressants. Cereb Cortex 2004, 14:224-229.
69. Roman F.S., Marchetti E. Involvement of 5-HT receptors in learning and memory. IDrugs 1998, 1:109-121.
70. Roychoudhury M., Kulkarni S.K. Antianxiety profile of ondansetron, a selective 5-HT3 antagonist, in a novel animal model. Methods Find Exp Clin Pharmacol 1997, 19:107-111.
71. Ryan B.K., Vollmayr B., Klyubin I., Gass P., Rowan M.J. Persistent inhibition of hippocampal long-term potentiation in vivo by learned helplessness stress. Hippocampus 2010, 20:758-767.
72. Shakesby A.C., Anwyl R., Rowan M.J. Overcoming the effects of stress on synaptic plasticity in the intact hippocampus: rapid actions of serotonergic and antidepressant agents. J Neurosci 2002, 22:3638-3644.
73. Staubli U., Xu F.B. Effects of 5-HT3 receptor antagonism on hippocampal theta rhythm, memory, and LTP induction in the freely moving rat. J Neurosci 1995, 15:2445-2452.
74. Tanaka K.F., Samuels B.A., Hen R. Serotonin receptor expression along the dorsal-ventral axis of mouse hippocampus. Philos Trans R Soc Lond B Biol Sci 2012, 367:2395-2401.
75. Tanti A., Belzung C. Neurogenesis along the septo-temporal axis of the hippocampus: are depression and the action of antidepressants region-specific?. Neuroscience 2013, 252:234-252.
76. van Goethem N.P., Rutten K., van der Staay F.J., Jans L.A., Akkerman S., Steinbusch H.W., et al. Object recognition testing: rodent species, strains, housing conditions, and estrous cycle. Behav Brain Res 2012, 232:323-334.
77. Vertes R.P. A PHA-L analysis of ascending projections of thedorsal raphe nucleus in the rat. J Comp Neurol 1991, 313:643-668.
78. Westrich L., Pehrson A., Zhong H., Nielsen S., Frederiksen K., Stensbol T.B., et al. In vitro and in vivo effects of the multimodal antidepressant vortioxetine (Lu AA21004) at human and rat targets. Int J Psychiatry Clin Pract 2012, 16:47.
79. Winters B.D., Bussey T.J. Glutamate receptors in perirhinal cortex mediate encoding, retrieval, and consolidation of object recognition memory. J Neurosci 2005, 25:4243-4251.
80. Xu L., Anwyl R., Rowan M.J. Behavioural stress facilitates the induction of long-term depression in the hippocampus. Nature 1997, 387:497-500.
81. Xu L., Holscher C., Anwyl R., Rowan M.J. Glucocorticoid receptor and protein/RNA synthesis-dependent mechanisms underlie the control of synaptic plasticity by stress. Proc Natl Acad Sci U S A 1998, 95:3204-3208.